|
Market Closed -
Nasdaq
23:00:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 22.96 USD | -2.30% |
|
-0.95% | -50.41% |
| 10-20 | Collegium Pharmaceutical Settles Nucynta Patent Litigation for $17 Million | MT |
| 10-09 | Collegium Pharmaceutical Outlook Supported by ADHD Trends, Low Generic Drug Risk, Oppenheimer Says | MT |
Chart calendar Collegium Pharmaceutical, Inc.
Upcoming events on Collegium Pharmaceutical, Inc.
| 05/11/2026 | Earnings release - Q3 2026 | |
| 05/11/2026 | Earnings presentation | 16:00 |
Past events on Collegium Pharmaceutical, Inc.
| 06/08/2026 | Earnings presentation | 15:00 |
| 06/08/2026 | Earnings release - Q2 2026 | |
| 14/05/2026 | Présentation aux Actionnaires / Analystes | 15:30 |
| 14/05/2026 | Annual General Meeting | 15:30 |
| 07/05/2026 | Earnings release - Q1 2026 | |
| 07/05/2026 | Earnings presentation | 15:00 |
| 19/03/2026 | Information meeting | 16:00 |
| 26/02/2026 | Earnings release - Q4 2025 | |
| 26/02/2026 | Earnings presentation | 16:00 |
| 06/11/2025 | Earnings presentation | 16:00 |
| 06/11/2025 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 567 565 0.38% | 631 629 0.36% | 781 781 -0.12% | 833 | 845 | 849 |
|
EBITDA Million USD | Released Forecast Spread | 367 366 0.34% | 401 399 0.65% | 460 457 0.87% | 448 | 414 | 375 |
|
EBIT Million USD | Released Forecast Spread | 167 153 8.91% | 170 177 -4.03% | 180 357 -49.71% | 449 | 402 | 377 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 75,7 61,4 23.27% | 98,6 106 -7.14% | 92,6 106 -12.78% | 55,8 | 155 | 223 |
|
Net income Million USD | Released Forecast Spread | 48,2 43,2 11.6% | 69,2 71,3 -2.99% | 62,9 76,6 -17.91% | 28,7 | 83,3 | 153 |
|
EPS USD | Released Forecast Spread | 1,29 1,10 17.27% | 1,86 1,86 0.18% | 1,73 1,94 -10.82% | 1,12 | 3,57 | 4,92 |
| Announcement Date | 22/02/24 | 27/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 182 180 1.26% | 178 173 2.7% | 188 181 3.93% | 209 189 10.7% | 205 206 -0.44% | 194 184 4.91% | 200 201 -0.53% | 216 | 224 | 195 | 206 | 211 | 219 |
|
EBITDA Million USD | Released Forecast Spread | 108 105 2.35% | 95,2 96,5 -1.4% | 105 104 1.35% | 133 117 13.51% | 127 126 0.89% | 104 102 2.13% | 114 108 5.02% | 114 | 118 | 107 | 114 | 116 | 122 |
|
EBIT Million USD | Released Forecast Spread | 38,1 45,3 -15.78% | 21,7 31,2 -30.52% | 35,1 36,8 -4.68% | 62,1 44,7 38.83% | 60,8 102 -40.55% | 103 97,8 5.78% | 112 106 5.53% | 115 | 122 | 85,9 | 93,7 | 96,6 | 102 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 17,3 24,8 -30.5% | 3,12 11,0 -71.63% | 17,0 16,0 6.39% | 43,4 26,9 61.32% | 29,0 42,6 -31.85% | 18,7 24,6 -23.82% | -13,5 | 22,8 | 27,9 | 20,3 | 27,2 | 30,5 | 36,7 |
|
Net income Million USD | Released Forecast Spread | 12,5 14,7 -14.52% | 2,42 7,92 -69.49% | 12,0 9,15 30.98% | 31,5 19,4 62.52% | 17,0 30,7 -44.7% | 14,5 17,7 -18.16% | -15,1 | 12,4 | 16,5 | 14,6 | 19,6 | 22,0 | 26,4 |
|
EPS USD | Released Forecast Spread | 0,36 0,39 -6.9% | 0,07 0,24 -70.21% | 0,34 0,23 47.83% | 0,84 0,50 68% | 0,46 0,77 -40.26% | 0,40 0,44 -9.09% | -0,46 | 0,51 | 0,64 | 0,37 | 0,50 | 0,55 | 0,66 |
| Announcement Date | 27/02/25 | 08/05/25 | 07/08/25 | 06/11/25 | 26/02/26 | 07/05/26 | 06/08/26 | - | - | - | - | - | - |
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 |
Past sector events for Collegium Pharmaceutical, Inc.
| Today | Information meeting | 01:30 | |
| Today | Information meeting | 03:15 | |
| 23/10/2026 | Earnings release - Q2 2027 | ||
| 23/10/2026 | Board of Directors Meeting | ||
| 23/10/2026 | Earnings presentation | 15:00 | |
| 23/10/2026 | Earnings release - Q2 2027 | ||
| 23/10/2026 | Earnings presentation | 17:00 | |
| 23/10/2026 | Board of Directors Meeting | 12:30 | |
| 23/10/2026 | Earnings release - Q3 2026 | ||
| 23/10/2026 | Board of Directors Meeting |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- COLL Stock
- Calendar Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
















